stockrowFulgent Genetics, Inc. (FLGT) vs Myriad Genetics, Inc. (MYGN)
- Fulgent Genetics, Inc. FLGT 22.43 +20.20%
- Myriad Genetics, Inc. MYGN 6.06 −3.66%
Fulgent Genetics, Inc. and Myriad Genetics, Inc. are both Diagnostics & Research companies. Myriad Genetics, Inc. is the larger, with a market value of $601.6M against $513.4M — 1.2× the size. Fulgent Genetics, Inc. grew revenue faster over the last twelve months: 4.67% against −3.16%. Myriad Genetics, Inc. has the higher net margin (−14.0% vs −27.5%) and the lower return on invested capital (−19.9% vs −8.22%). Across the 18 metrics below, Fulgent Genetics, Inc. leads on 11 and Myriad Genetics, Inc. on 7.
Valuation
Profitability
| Metric | FLGT | MYGN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.82% | 68.83% | 48.32% |
| Operating margin | (39.20%) | (12.22%) | (5.68%) |
| Net margin | (27.53%) | (13.96%) | (4.10%) |
| Free cash flow margin | 4.37% | (1.76%) | 0.00% |
| Return on equity | (8.64%) | (32.54%) | 0.00% |
| Return on assets | (7.93%) | (17.11%) | (6.05%) |
| Return on invested capital | (8.22%) | (19.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack